Principal Engineer - Biomedical at Eli Lilly and Company

Singapore, Singapore, Singapore

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Pharmaceuticals, Digital HealthIndustries

Requirements

Ph.D. in Biomedical, Mechanical, or Electrical Engineering OR Master's Degree with 3+ years of experience in testing of human movement and human physiology
3+ years of experience working with and programming digital sensors
2+ years of experience conducting signal processing analytics
2+ years of experience using computer programming skills
Background in motion capture systems, actigraphy, inertial-measurement-unit (IMU), photoplethysmography, electrocardiography, and other biomedical signals
Proficiency in operating biomedical research devices, developing signal processing pipelines, and analytical tools

Responsibilities

Develop and manage DHT testing capabilities, including collaborating with senior Biomedical Engineering members to build biomedical testing capabilities for DHTs, managing lab space and equipment, and handling DHTs for in-house testing
Assist in developing in-house evaluation tests and user acceptance tests (UATs) for related DHTs
Assist in managing and setting up in-house evaluation tests, including scheduling sessions and monitoring participants
Support data preparation and analysis for in-house evaluations and UATs
Collaborate with senior Biomedical Engineer members to conduct testing over multiple DHTs and integrate biomedical data into advanced analytics platforms
Design, develop, and maintain data pipelines and workflows to process biomedical datasets
Utilize Python and R for data wrangling, analysis, and visualization to support research and development initiatives
Apply principles of biomedical engineering to solve problems related to signal processing, imaging, and physiological data interpretation
Ensure the quality, security, and scalability of biomedical data solutions
Perform exploratory data analysis and generate insights to inform product development and clinical research
Stay updated on emerging technologies and methodologies in biomedical data engineering and analytics

Skills

Biomedical Engineering

Signal Processing

Sensor Technology

Data Analytics

Wearable Sensors

Motion Capture

Actigraphy

IMU

Photoplethysmography

Electrocardiography

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free